{"id":3430,"date":"2019-12-30T09:24:30","date_gmt":"2019-12-30T08:24:30","guid":{"rendered":"https:\/\/www.delucapartners.it\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/"},"modified":"2026-02-10T12:10:23","modified_gmt":"2026-02-10T11:10:23","slug":"the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties","status":"publish","type":"case-history","link":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/","title":{"rendered":"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties."},"content":{"rendered":"\n<p>The operation involved analysing and solving complex issues associated with contract working and manpower supply, which were decisive in the operation\u2019s feasibility study. Of particular importance, in this case, were the regulations applying to fixed term contracts and the derogations from the quantity restrictions set in the CCNL collective bargaining agreement during the negotiations at company level.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The operation involved analysing and solving complex issues associated with contract working and manpower supply, which were decisive in the operation\u2019s feasibility study. Of particular importance, in this case, were the regulations applying to fixed term contracts and the derogations from the quantity restrictions set in the CCNL collective bargaining agreement during the negotiations at [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":30016,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"ch_sector":[48],"ch_type":[46],"class_list":["post-3430","case-history","type-case-history","status-publish","has-post-thumbnail","hentry","ch_sector-pharmaceutical","ch_type-ma-extraordinary-operations"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties. - De Luca &amp; Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/case-history\/3430\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties. - De Luca &amp; Partners\" \/>\n<meta property=\"og:description\" content=\"The operation involved analysing and solving complex issues associated with contract working and manpower supply, which were decisive in the operation\u2019s feasibility study. Of particular importance, in this case, were the regulations applying to fixed term contracts and the derogations from the quantity restrictions set in the CCNL collective bargaining agreement during the negotiations at [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/\" \/>\n<meta property=\"og:site_name\" content=\"De Luca &amp; Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-10T11:10:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2026\/02\/Pharma_1920x820-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"820\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/\",\"url\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/\",\"name\":\"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties. - De Luca &amp; Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.delucapartners.it\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/9.2.jpg\",\"datePublished\":\"2019-12-30T08:24:30+00:00\",\"dateModified\":\"2026-02-10T11:10:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.delucapartners.it\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/9.2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.delucapartners.it\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/9.2.jpg\",\"width\":1200,\"height\":790},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/case-history\\\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/\",\"name\":\"De Luca & Partners\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/#organization\",\"name\":\"De Luca & Partners\",\"url\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.delucapartners.it\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/De-Luca-Partners.png\",\"contentUrl\":\"https:\\\/\\\/www.delucapartners.it\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/De-Luca-Partners.png\",\"width\":600,\"height\":56,\"caption\":\"De Luca & Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/www.delucapartners.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties. - De Luca &amp; Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/case-history\/3430\/","og_locale":"en_US","og_type":"article","og_title":"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties. - De Luca &amp; Partners","og_description":"The operation involved analysing and solving complex issues associated with contract working and manpower supply, which were decisive in the operation\u2019s feasibility study. Of particular importance, in this case, were the regulations applying to fixed term contracts and the derogations from the quantity restrictions set in the CCNL collective bargaining agreement during the negotiations at [&hellip;]","og_url":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/","og_site_name":"De Luca &amp; Partners","article_modified_time":"2026-02-10T11:10:23+00:00","og_image":[{"width":1920,"height":820,"url":"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2026\/02\/Pharma_1920x820-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/","url":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/","name":"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties. - De Luca &amp; Partners","isPartOf":{"@id":"https:\/\/www.delucapartners.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/#primaryimage"},"image":{"@id":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/#primaryimage"},"thumbnailUrl":"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2019\/12\/9.2.jpg","datePublished":"2019-12-30T08:24:30+00:00","dateModified":"2026-02-10T11:10:23+00:00","breadcrumb":{"@id":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/#primaryimage","url":"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2019\/12\/9.2.jpg","contentUrl":"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2019\/12\/9.2.jpg","width":1200,"height":790},{"@type":"BreadcrumbList","@id":"https:\/\/www.delucapartners.it\/en\/case-history\/the-firm-assisted-the-fund-in-the-acquisition-of-a-pharmaceutics-company-active-in-the-planning-and-implementation-of-scientific-information-campaigns-on-drugs-on-behalf-of-third-parties\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.delucapartners.it\/en\/"},{"@type":"ListItem","position":2,"name":"The Firm assisted the fund in the acquisition of a pharmaceutics company active in the planning and implementation of scientific information campaigns on drugs on behalf of third parties."}]},{"@type":"WebSite","@id":"https:\/\/www.delucapartners.it\/en\/#website","url":"https:\/\/www.delucapartners.it\/en\/","name":"De Luca & Partners","description":"","publisher":{"@id":"https:\/\/www.delucapartners.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delucapartners.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.delucapartners.it\/en\/#organization","name":"De Luca & Partners","url":"https:\/\/www.delucapartners.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delucapartners.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2026\/01\/De-Luca-Partners.png","contentUrl":"https:\/\/www.delucapartners.it\/wp-content\/uploads\/2026\/01\/De-Luca-Partners.png","width":600,"height":56,"caption":"De Luca & Partners"},"image":{"@id":"https:\/\/www.delucapartners.it\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/case-history\/3430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/case-history"}],"about":[{"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/types\/case-history"}],"author":[{"embeddable":true,"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/users\/5"}],"version-history":[{"count":1,"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/case-history\/3430\/revisions"}],"predecessor-version":[{"id":3432,"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/case-history\/3430\/revisions\/3432"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/media\/30016"}],"wp:attachment":[{"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/media?parent=3430"}],"wp:term":[{"taxonomy":"ch_sector","embeddable":true,"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/ch_sector?post=3430"},{"taxonomy":"ch_type","embeddable":true,"href":"https:\/\/www.delucapartners.it\/en\/wp-json\/wp\/v2\/ch_type?post=3430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}